Trexquant Investment LP Celldex Therapeutics, Inc. Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$32.76 - $42.56 $2.49 Million - $3.23 Million	-75,930 Reduced 86.26%	12,092 $447,000
Q1 2024 May 14, 2024	BUY	$35.22 - $51.88 $1.99 Million - $2.94 Million	56,593 Added 180.07%	88,022 $3.69 Million
Q4 2023 Feb 09, 2024	BUY	$22.61 - $40.65 $710,609 - $1.28 Million	31,429 New	31,429 $1.25 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $302,273 - $500,282	13,316 New	13,316 $374,000
Q1 2022 May 13, 2022	SELL	$27.64 - $39.32 $245,691 - $349,515	-8,889 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $59,942 - $94,533	1,680 Added 23.3%	8,889 $343,000
Q3 2021 Nov 12, 2021	BUY	$28.95 - $55.99 $208,700 - $403,631	7,209 New	7,209 $389,000

203

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.11B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.